Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice

Open Access

Peer-reviewed

Research Article

Mohammad S. Hossain,

Affiliation Department of Hematology and Medical Oncology, Division of Stem Cell and Bone Marrow Transplantation, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, United States of America
⨯
Sampath Ramachandiran,

Affiliation Department of Hematology and Medical Oncology, Division of Stem Cell and Bone Marrow Transplantation, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, United States of America
⨯
Andrew T. Gewirtz,

Affiliation Department of Biology, Georgia State University, Atlanta, Georgia, United States of America
⨯
Edmund K. Waller

* E-mail: ewaller@emory.edu

Affiliation Department of Hematology and Medical Oncology, Division of Stem Cell and Bone Marrow Transplantation, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, United States of America
⨯

Reader Comments (0)

NK cells
Is the Subject Area "NK cells" applicable to this article?

Thanks for your feedback.
Cell-mediated immunity
Is the Subject Area "Cell-mediated immunity" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Opportunistic infections
Is the Subject Area "Opportunistic infections" applicable to this article?

Thanks for your feedback.
Flagellin
Is the Subject Area "Flagellin" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Viral load
Is the Subject Area "Viral load" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.